> top > docs > PMC:7299399 > spans > 19337-20231 > annotations

PMC:7299399 / 19337-20231 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T89 199-203 Body_part denotes mRNA http://purl.org/sig/ont/fma/fma67122
T90 213-217 Body_part denotes mRNA http://purl.org/sig/ont/fma/fma67122
T91 240-245 Body_part denotes lipid http://purl.org/sig/ont/fma/fma67264
T92 659-662 Body_part denotes DNA http://purl.org/sig/ont/fma/fma74412

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T192 36-37 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T193 163-164 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T194 188-195 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T195 250-251 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T196 378-380 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T197 657-658 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T198 716-719 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T199 757-768 http://purl.obolibrary.org/obo/NCBITaxon_10141 denotes guinea pigs
T200 782-783 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T201 842-845 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T202 862-869 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T203 873-879 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T128 240-245 Chemical denotes lipid http://purl.obolibrary.org/obo/CHEBI_18059
T129 246-249 Chemical denotes NPs http://purl.obolibrary.org/obo/CHEBI_50803
T130 619-621 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T131 659-662 Chemical denotes DNA http://purl.obolibrary.org/obo/CHEBI_16991

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T84 0-94 Sentence denotes On March 16, 2020, Moderna, through a partnership with the Vaccine Research Center at the U.S.
T85 95-656 Sentence denotes National Institutes of Health, enrolled the first participants into a Phase I clinical trial testing an mRNA vaccine (mRNA-1273) encapsulated in lipid NPs—a record time of just 63 days following sequence selection (NCT04283461).65 The enrollment of the first cohort of participants (18 to 55-year-old healthy subjects) concluded on April 16, 2020.66 CureVac and BioNTech (in partnership with Pfizer) are currently working on similar vaccines; Pfizer/BioNTech, in particular, have recently started the recruitment in Phase I/II trials (NCT04368728, NCT04380701).
T86 657-894 Sentence denotes A DNA plasmid vaccine by Inovio Pharmaceuticals (INO-4800) has showed promising results in mice and guinea pigs according to a recent article published in Nature Communications(67) and has entered Phase I testing in humans (NCT04336410).

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
284 611-621 Gene denotes Phase I/II
285 92-93 Gene denotes S Gene:43740568
286 145-157 Species denotes participants Tax:9606
287 364-376 Species denotes participants Tax:9606
288 748-752 Species denotes mice Tax:10090
289 757-768 Species denotes guinea pigs Tax:10141
290 873-879 Species denotes humans Tax:9606
291 240-245 Chemical denotes lipid MESH:D008055

2_test

Id Subject Object Predicate Lexical cue
32519842-32433465-158491 834-836 32433465 denotes 67